UNSPSC 51332852: Fluphenazine hydrochloride

This classification denotes an antipsychotic agent with the molecular formula C22H26F3N3OS.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZOU145W1XL, chemically known as 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)- but more generally known as fluphenazine dihydrochloride, which bears US NIH Compound Identifier 3372. European Medicines Agency schedules Fluphenazine dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02232MIG.

UNSPSC 51332852 Fluphenazine hydrochloride is a Commodity code that nominally designates a specific antipsychotic pharmaceutical, yet the single recent state and local opportunity on record does not align with this scope — Seminole County, Florida posted an IFB for naloxone (an opioid antagonist) and drug deactivation systems in June 2026, a procurement unrelated to fluphenazine products. The code shows little relevant recent activity for business development purposes at the state and local level. State and local governments soliciting under this Commodity do not appear to have posted opportunities that match the pharmaceutical's actual scope.

The mismatch between the code's nominal pharmaceutical scope and the naloxone-focused IFB suggests either a coding error in the opportunity classification or minimal market activity for fluphenazine under this UNSPSC designation among state and local buyers. Without additional recent opportunities aligned to the fluphenazine product line itself, this code does not present a clear procurement signal for firms positioning capacity in antipsychotic medications or related pharmaceutical supply.